Add to ORKGRughetti A, Pellicciotta I, Biffoni M, et al. Recombinant tumor associated MUC1 impairs differentiation and function of Dendritic Cells. Journal of Immunology. 2005;174(12):7764-7772
Type 1 conventional dendritic cells are necessary for the development of anti-tumor immunity. In thi...
BACKGROUND: Gastric carcinoma is the second leading cause of cancer-associated death worldwide. The ...
<p><b>(A)</b> Tumor cell expression of MUC1 was stable <i>in vitro</i> (C57mg.MUC1: 86%; KCM: 73%; E...
Tumors exploit several strategies to evade immune recognition, including the production of a large n...
Tumors exploit several strategies to evade immune recognition, including the production of a large n...
The immunostimulatory outcome of the interactions of many pathogens with dendritic cells (DC) has be...
Beatson R, Tajadura-Ortega V, Achkova D, et al. The mucin MUC1 modulates the tumor immunological mic...
Dendritic cells (DCs) are the best professional antigen-presenting cells to stimulate cytotoxic as w...
In vivo studies showed that dendritic cell (DC) dysfunction occurred in tumor microenvironment. As t...
Dendritic cells (DCs) are a heterogenous population of professional antigen presenting cells whose m...
Beatson R, Graham R, Grundland Freile F, et al. Cancer-associated hypersialylated MUC1 drives the di...
Grimshaw MJ, Papazisis K, Picco G, et al. Immunisation with 'naive' syngeneic dendritic cells protec...
Abstract Perpetuation of immune deficiency throughout tumor development is, to a great degree, the r...
The generation and progress of tumors are accompanied with a marked suppression of human immune syst...
The type of interaction between tumor-associated antigens and specialized antigen-presenting cells s...
Type 1 conventional dendritic cells are necessary for the development of anti-tumor immunity. In thi...
BACKGROUND: Gastric carcinoma is the second leading cause of cancer-associated death worldwide. The ...
<p><b>(A)</b> Tumor cell expression of MUC1 was stable <i>in vitro</i> (C57mg.MUC1: 86%; KCM: 73%; E...
Tumors exploit several strategies to evade immune recognition, including the production of a large n...
Tumors exploit several strategies to evade immune recognition, including the production of a large n...
The immunostimulatory outcome of the interactions of many pathogens with dendritic cells (DC) has be...
Beatson R, Tajadura-Ortega V, Achkova D, et al. The mucin MUC1 modulates the tumor immunological mic...
Dendritic cells (DCs) are the best professional antigen-presenting cells to stimulate cytotoxic as w...
In vivo studies showed that dendritic cell (DC) dysfunction occurred in tumor microenvironment. As t...
Dendritic cells (DCs) are a heterogenous population of professional antigen presenting cells whose m...
Beatson R, Graham R, Grundland Freile F, et al. Cancer-associated hypersialylated MUC1 drives the di...
Grimshaw MJ, Papazisis K, Picco G, et al. Immunisation with 'naive' syngeneic dendritic cells protec...
Abstract Perpetuation of immune deficiency throughout tumor development is, to a great degree, the r...
The generation and progress of tumors are accompanied with a marked suppression of human immune syst...
The type of interaction between tumor-associated antigens and specialized antigen-presenting cells s...
Type 1 conventional dendritic cells are necessary for the development of anti-tumor immunity. In thi...
BACKGROUND: Gastric carcinoma is the second leading cause of cancer-associated death worldwide. The ...
<p><b>(A)</b> Tumor cell expression of MUC1 was stable <i>in vitro</i> (C57mg.MUC1: 86%; KCM: 73%; E...